CVRx, Inc. PE Ratio
The price-to-earnings (P/E) ratio tells you how many dollars investors pay for each dollar of a company's annual profit. It is market capitalization divided by net income over the trailing four quarters, meaning the four most recent filed quarters added together, and the table shows both amounts. A higher P/E means investors are paying more for each dollar of current earnings, often because they expect profits to grow; a negative P/E means the company lost money over those four quarters. Each point uses the filed share count and the last closing price on or before that quarter-end date, never today's price.
- CVRx, Inc. pe ratio for the quarter ending 2026-06-30 was -2.62, a change of 0.32 year-over-year.
- CVRx, Inc. pe ratio for the quarter ending 2026-03-31 was -4.73, a change of 1.45 year-over-year.
- CVRx, Inc. pe ratio for the quarter ending 2025-12-31 was -3.51, a change of 1.84 year-over-year.
- CVRx, Inc. pe ratio for the quarter ending 2025-09-30 was -4.07, a change of -0.43 year-over-year.
- CVRx, Inc. pe ratio for fiscal 2026 was -2.62.
- CVRx, Inc. pe ratio for fiscal 2025 was -3.51, a change of 1.84 from fiscal 2024.
- CVRx, Inc. pe ratio for fiscal 2024 was -5.35, a change of 10.58 from fiscal 2023.
- CVRx, Inc. pe ratio for fiscal 2023 was -15.93, a change of -6.78 from fiscal 2022.
- Available history
- 2021-06-30 to 2026-06-30
- Data captured
Historical PE Ratio
Annual PE Ratio
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 | |
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| RenovoRx, Inc. (RNXT) | United States | $0.076B | -3.62 |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| Pulmonx Corp (LUNG) | United States | $0.082B | -1.16 |
| Spectral AI, Inc. (MDAI) | United States | $0.052B | |
| Sensus Healthcare, Inc. (SRTS) | United States | $0.048B | -3.24 |
| SkinHealth Systems Inc. (SKIN) | United States | $0.086B | -3.17 |
| LENSAR, Inc. (LNSR) | United States | $0.087B | 2.02 |